XFOR
X4 Pharmaceuticals Inc
2.90$
+2.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 2.0% | – | 82.1% | 54.8% | 21.1% | 17.4% | 25.0% | 21.2% | 15.1% | 22.1% | 18.4% | 18.8% | |
| – | -2.0% | – | 17.9% | 45.2% | 78.9% | 82.6% | 75.0% | 78.8% | 84.9% | 77.9% | 81.6% | 81.2% | |
| – | 497.1% | – | 3,680.3% | 3,409.5% | 1,513.4% | 63.3% | 921.6% | 981.0% | 720.3% | 570.5% | 171.2% | 418.6% | |
| – | 324.4% | – | 2,358.4% | 2,796.4% | 1,056.1% | 52.1% | 482.9% | 656.4% | 1,694.5% | 257.2% | 96.5% | 445.3% | |
| – | 821.5% | – | 6,038.7% | 6,205.9% | 2,569.5% | 115.4% | 1,404.5% | 1,637.4% | 1,007.8% | 827.8% | 267.8% | 635.9% | |
| – | -823.5% | – | -6,020.8% | -6,160.7% | -2,490.6% | -32.8% | -1,329.5% | -1,558.6% | -922.9% | -749.9% | -186.1% | -554.7% | |
| – | 61.6% | – | 386.5% | 431.1% | 160.7% | 7.6% | 113.1% | 127.9% | 85.1% | 78.8% | 24.6% | 55.2% | |
| – | -624.1% | – | 16,136.9% | -6,550.2% | -2,758.9% | 1.1% | -1,302.8% | -1,690.9% | -931.7% | -747.5% | -183.5% | -569.0% | |
| – | 1.1% | – | 3.2% | 2.7% | 18.0% | 0.1% | 1.9% | -1.7% | – | – | 0.0% | – | |
| – | -625.2% | – | 16,133.7% | -6,552.9% | -2,776.9% | 1.0% | -1,304.7% | -1,689.2% | -931.7% | -747.5% | -183.5% | -568.8% | |
| – | -560.4% | – | 16,557.9% | -6,069.1% | -2,579.2% | 10.4% | -1,171.0% | -1,550.4% | -837.9% | -659.9% | -145.0% | -501.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.